S K Garg

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. doi request reprint Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial
    Satish K Garg
    Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Center Aurora, Colorado Diabetes Technology and Therapeutics University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
    Endocr Pract 19:19-28. 2013
  2. doi request reprint Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study
    Satish Garg
    Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, USA
    Diabetes Technol Ther 14:205-9. 2012
  3. doi request reprint Preference for a new prefilled insulin pen compared with the original pen
    S Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO 80045, USA
    Curr Med Res Opin 27:2323-33. 2011
  4. doi request reprint Self-monitoring of blood glucose
    S K Garg
    University of Colorado Health Science Center, Aurora, CO, USA
    Int J Clin Pract Suppl . 2011
  5. pmc Clinical experience with insulin glargine in type 1 diabetes
    Satish Garg
    Barbara Davis Campus for Childhood Diabetes, University of Colorado Denver, 1775 Aurora Court, Aurora, CO 80045, USA
    Diabetes Technol Ther 12:835-46. 2010
  6. doi request reprint Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus
    Satish Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, Colorado 80045, USA
    Endocr Pract 16:486-505. 2010
  7. doi request reprint The role of basal insulin and glucagon-like peptide-1 agonists in the therapeutic management of type 2 diabetes--a comprehensive review
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 12:11-24. 2010
  8. doi request reprint Effects of colesevelam on LDL-C, A1c and GLP-1 levels in patients with type 1 diabetes: a pilot randomized double-blind trial
    S K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
    Diabetes Obes Metab 13:137-43. 2011
  9. doi request reprint Time lag characterization of two continuous glucose monitoring systems
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, School of Medicine, Aurora, CO 80045, United States
    Diabetes Res Clin Pract 87:348-53. 2010
  10. doi request reprint Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, USA
    Diabetes Technol Ther 11:S5-S16. 2009

Collaborators

Detail Information

Publications45

  1. doi request reprint Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial
    Satish K Garg
    Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Center Aurora, Colorado Diabetes Technology and Therapeutics University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
    Endocr Pract 19:19-28. 2013
    ....
  2. doi request reprint Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study
    Satish Garg
    Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, USA
    Diabetes Technol Ther 14:205-9. 2012
    ..The efficacy of automatic suspension of insulin delivery in induced hypoglycemia among subjects with type 1 diabetes was evaluated...
  3. doi request reprint Preference for a new prefilled insulin pen compared with the original pen
    S Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO 80045, USA
    Curr Med Res Opin 27:2323-33. 2011
    ..The prevalence of diabetes is increasing in the United States and worldwide. Insulin injection pens are preferred over vial/syringe methods, and are designed to facilitate use, improve adherence, and provide accurate insulin delivery...
  4. doi request reprint Self-monitoring of blood glucose
    S K Garg
    University of Colorado Health Science Center, Aurora, CO, USA
    Int J Clin Pract Suppl . 2011
    ..Although SMBG is not 'new' technology, much research needs to be completed before we fully understand this tool's full impact, particularly as CGM becomes more popular...
  5. pmc Clinical experience with insulin glargine in type 1 diabetes
    Satish Garg
    Barbara Davis Campus for Childhood Diabetes, University of Colorado Denver, 1775 Aurora Court, Aurora, CO 80045, USA
    Diabetes Technol Ther 12:835-46. 2010
    ..However, these same trials show a significantly lower risk for hypoglycemia with insulin glargine compared with NPH insulin in adults...
  6. doi request reprint Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus
    Satish Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, Colorado 80045, USA
    Endocr Pract 16:486-505. 2010
    ..To compare rapid-acting insulin analogues with regular human insulin in terms of hemoglobin A1c, hypoglycemia, and insulin dose when used in a basal-bolus regimen in patients with type 1 diabetes mellitus...
  7. doi request reprint The role of basal insulin and glucagon-like peptide-1 agonists in the therapeutic management of type 2 diabetes--a comprehensive review
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 12:11-24. 2010
    ..Further comparative data are needed to fully investigate the relative positioning of these therapies within the T2DM treatment paradigm...
  8. doi request reprint Effects of colesevelam on LDL-C, A1c and GLP-1 levels in patients with type 1 diabetes: a pilot randomized double-blind trial
    S K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
    Diabetes Obes Metab 13:137-43. 2011
    ..colesevelam is indicated to lower low density lipoprotein cholesterol (LDL-C) in hyperlipidaemia and improve glycaemic control in adults with type 2 diabetes. This short-term pilot study evaluates its effects in type 1 diabetes...
  9. doi request reprint Time lag characterization of two continuous glucose monitoring systems
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, School of Medicine, Aurora, CO 80045, United States
    Diabetes Res Clin Pract 87:348-53. 2010
    ....
  10. doi request reprint Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, USA
    Diabetes Technol Ther 11:S5-S16. 2009
    ..AIR((R)) inhaled insulin (system from Eli Lilly and Company, Indianapolis, IN) (AIR is a registered trademark of Alkermes, Inc., Cambridge, MA) may be an efficacious and safe alternative to subcutaneously injected (SC) mealtime insulin...
  11. pmc Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, School of Medicine, Aurora, Colorado, USA
    Diabetes Care 34:574-9. 2011
    ..To compare use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injection (MDI) therapy versus continuous subcutaneous insulin infusion (CSII) therapy for 6 months...
  12. doi request reprint Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, School of Medicine, University of Colorado at Denver, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 11:65-72. 2009
    ....
  13. doi request reprint Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial
    S L Ellis
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO 80045, USA
    Diabet Med 28:1176-81. 2011
    ..This study evaluates the clinical implications of sitagliptin in adult patients with Type 1 diabetes...
  14. ncbi request reprint Long-term efficacy of humalog in subjects with Type 1 diabetes mellitus
    S K Garg
    Barbara Davis Center for Childhood Diabetes, Department of Paediatrics, University of Colorado Health Sciences Center, Denver, USA
    Diabet Med 16:384-7. 1999
    ..To evaluate the long-term effectiveness of Humalog insulin in lowering post meal glucose excursions...
  15. ncbi request reprint The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes
    H P Chase
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Diabetes Care 24:430-4. 2001
    ....
  16. ncbi request reprint Review of phase 2 studies utilizing the AIR particle technology in the delivery of human insulin inhalation powder versus subcutaneous regular or lispro insulin in subjects with type 1 or type 2 diabetes
    Samuel L Ellis
    Barbara Davis Center for Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 9:S48-56. 2007
    ..Phase 3 studies are ongoing to further evaluate safety and efficacy of HIIP...
  17. ncbi request reprint Use of continuous glucose monitoring in patients with type 1 diabetes
    Samuel L Ellis
    Barbara Davis Center for Diabetes, University of Colorado Denver, A140, P O Box 6511 Aurora, CO 80045, USA
    Curr Diabetes Rev 4:207-17. 2008
    ..In addition, for better clinical care and usage, algorithms also need to be developed for both patients and the providers to guide them for their ongoing diabetes care...
  18. ncbi request reprint Optimized Basal-bolus insulin regimens in type 1 diabetes: insulin glulisine versus regular human insulin in combination with Basal insulin glargine
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Endocr Pract 11:11-7. 2005
    ..To compare the efficacy and safety of insulin glulisine (GLU), a new rapid-acting insulin analogue, injected 0 to 15 minutes before or immediately after meals, with regular human insulin (RHI), injected 30 to 45 minutes before meals...
  19. pmc Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 10:369-75. 2008
    ..Management of type 1 diabetes could be significantly improved with the availability of computerized insulin algorithms for home use...
  20. ncbi request reprint Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes
    S K Garg
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver 80262, USA
    Diabetes Care 22:1708-14. 1999
    ..Redwood City, CA) with capillary blood glucose values that were determined 1) in a controlled outpatient clinic setting and 2) in a home setting...
  21. ncbi request reprint Continuous subcutaneous glucose monitoring in children with type 1 diabetes
    H P Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, Denver, Colorado 80262, USA
    Pediatrics 107:222-6. 2001
    ....
  22. ncbi request reprint Use of the GlucoWatch biographer in children with type 1 diabetes
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Pediatrics 111:790-4. 2003
    ..To determine whether use of the GlucoWatch biographer improves glucose control in children and adolescents with type 1 diabetes...
  23. ncbi request reprint Reduced severe hypoglycemia with insulin glargine in intensively treated adults with type 1 diabetes
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Technol Ther 6:589-95. 2004
    ..The goal of new therapies introduced for type 1 diabetes should be to decrease hypoglycemic episodes while improving glycemic control...
  24. ncbi request reprint Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes
    Satish K Garg
    Department of Medicine, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA
    Endocr Pract 9:187-93. 2003
    ..To evaluate glycemic control and maternal and fetal outcomes of patients with type 1 diabetes treated with insulin lispro before and during pregnancy...
  25. ncbi request reprint Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver, Colorado, USA
    J Pediatr 143:737-40. 2003
    ..The numbers of nonsevere and severe hypoglycemic events, hemoglobin A1c values, body weight, and daily insulin dose were recorded at each clinic visit...
  26. ncbi request reprint Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Technol Ther 6:9-15. 2004
    ..However, costs and episodes of diabetic ketoacidosis are significantly higher for insulin pump users...
  27. ncbi request reprint Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes
    Satish K Garg
    Department of Medicine and Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Care 27:734-8. 2004
    ..The capability of emerging glucose sensor technology to continuously monitor glucose levels may provide ways to achieve glycemic targets while reducing hypoglycemia...
  28. ncbi request reprint Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes
    H P Chase
    Department of Paediatrics, Barbara Davis Center, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabet Med 19:317-21. 2002
    ..To determine if one method of short-acting insulin bolus administration is superior to other methods in managing a meal high in carbohydrates, calories and fat...
  29. ncbi request reprint Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, Colorado, USA
    Diabetes Care 30:3023-5. 2007
  30. ncbi request reprint Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabetes Res Clin Pract 66:49-56. 2004
    ..Sixty-three subjects were taking glargine in the morning, 125 were taking glargine in the evening, and 104 were splitting the glargine dose between the morning and evening...
  31. pmc Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine
    Heather Ulrich
    Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Denver, CO 80232, USA
    Vasc Health Risk Manag 3:245-54. 2007
    ..In summary, insulin glulisine is a safe, effective, and well tolerated rapid-acting insulin analogue across all BMIs and a worthy option for prandial glucose control in type 1 or 2 DM...
  32. pmc Feasibility of 10-day use of a continuous glucose-monitoring system in adults with type 1 diabetes
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, USA
    Diabetes Care 32:436-8. 2009
    ..The purpose of this pilot study was to evaluate the feasibility of 10-day use of a transcutaneous, real-time, continuous glucose-monitoring (CGM) system. All previous reports using different CGM systems were for 3-, 5-, or 7-day use...
  33. ncbi request reprint Health impact from frequent and continuous glucose monitoring
    Satish K Garg
    Department of Medicine and Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Technol Ther 6:523-4. 2004
  34. ncbi request reprint Use of insulin glargine in children under age 6 with type 1 diabetes
    Brenner Dixon
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO, USA
    Pediatr Diabetes 6:150-4. 2005
    ..The purpose of this study is to evaluate the use of insulin glargine (Lantus in children under age 6 with type 1 diabetes (T1D)...
  35. ncbi request reprint The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes
    A Kretowski
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Mail Stop A140, P O Box 6511, Aurora, CO 80045 6511, USA
    Diabetologia 49:1946-54. 2006
    ..The aim of the present study was to evaluate the association of apolipoprotein A-IV (APOA4) polymorphisms with coronary artery calcification (CAC) progression, a marker of subclinical atherosclerosis...
  36. ncbi request reprint Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 E 9th Ave B140, Denver, CO 80262, USA
    Expert Opin Pharmacother 6:643-51. 2005
    ..In conclusion, insulin glulisine is an effective, safe and well-tolerated rapid-acting insulin analogue...
  37. ncbi request reprint 24-h ambulatory blood pressure monitoring in healthy young adult Anglo, Hispanic, and African-American subjects
    H P Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Am J Hypertens 10:18-23. 1997
    ..It also shows that higher blood pressures are present among males and among subjects of African-American descent in the teenage and young adult population...
  38. ncbi request reprint The role of continuous glucose sensors in diabetes care
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Campus Box B 140, Denver, CO 80262, USA
    Endocrinol Metab Clin North Am 33:163-73, x-xi. 2004
  39. ncbi request reprint Modem transmission of glucose values reduces the costs and need for clinic visits
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Diabetes Care 26:1475-9. 2003
    ..To determine whether modem technology allows for effective management of type 1 diabetes when used in lieu of a clinic visit...
  40. ncbi request reprint Optimizing insulin therapy in pregnant women with type 1 diabetes mellitus
    Peter A Gottlieb
    Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Treat Endocrinol 1:235-40. 2002
    ..No studies of insulin aspart in pregnancy have been published in full. In addition to optimization of glycemic control, frequent assessment for development and/or progression of microvascular complications is necessary during pregnancy...
  41. ncbi request reprint New insulin analogues
    Satish K Garg
    University of Colorado, Denver, Colorado, USA
    Diabetes Technol Ther 7:813-7. 2005
  42. ncbi request reprint Use of continuous glucose monitoring to improve diabetes mellitus management
    Samuel L Ellis
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, Colorado, USA
    Endocrinol Metab Clin North Am 36:46-68. 2007
  43. ncbi request reprint Awareness and treatment of dyslipidemia in young adults with type 1 diabetes
    R Paul Wadwa
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Ave, Box B140, Denver, CO 80262, USA
    Diabetes Care 28:1051-6. 2005
    ..In this report, we describe the prevalence of dyslipidemia and adequacy of pharmacological treatment in patients with type 1 diabetes and comparable nondiabetic subjects...
  44. ncbi request reprint The clinical performance and ease of use of a blood glucose meter that uses a 10-test disk
    Satish K Garg
    Department of Medicine and Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Diabetes Technol Ther 6:495-502. 2004
    ..Subjects found the meter easy and intuitive to learn to use. The study subjects were able to correctly use the meter after independently reviewing the user guide...
  45. ncbi request reprint Inflammatory markers and diabetic retinopathy in type 1 diabetes
    Kenneth E Izuora
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Ave, Box B 140, Denver, CO, USA
    Diabetes Care 28:714-5. 2005